Evidence map›Paper›PMID 28827664›Full record

ArticleScientific reports2017

Integrated analysis of mRNA and miRNA expression in HeLa cells expressing low levels of Nucleolin.

Sanjeev Kumar, Elizabhet Cruz Gomez, Mounira Chalabi-Dchar, Cong Rong, Sadhan Das, Iva Ugrinova, Xavier Gaume, Karine Monier, Fabien Mongelard, Philippe Bouvet

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Identification of a conserved RNA structure in thebioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. DruggableCancers · 2018
    Article
  18. Super-resolution Geometric Barcoding for Multiplexed miRNA Profiling.Angewandte Chemie (International ed. in English) · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Sanjeev KumarBioCOS Life Sciences Private Limited, AECS Layout, B-Block, Singasandra Hosur Road SAAMI Building, 851/A, 3rd Floor, Bengaluru, Karnataka, India. sanjeev@biocosls.in.
Elizabhet Cruz GomezUniversité de Lyon, Centre de Recherche en Cancérologie de Lyon, Cancer Cell Plasticity Department, UMR INSERM 1052 CNRS, 5286, Centre Léon Bérard, Lyon, France.
Mounira Chalabi-DcharUniversité de Lyon, Centre de Recherche en Cancérologie de Lyon, Cancer Cell Plasticity Department, UMR INSERM 1052 CNRS, 5286, Centre Léon Bérard, Lyon, France.
Cong RongUniversité de Lyon, Ecole Normale Supérieure de Lyon, Lyon, France.
Sadhan DasUniversité de Lyon, Ecole Normale Supérieure de Lyon, Lyon, France.
Iva UgrinovaInstitute of Molecular Biology "Acad. Roumen Tsanev" Bulgarian Academy of Sciences "Acad. G Bonchev str. bl. 21, 1113, Sofia, Bulgaria.ORCID 0000-0002-0116-0079
Xavier GaumeUniversité de Lyon, Ecole Normale Supérieure de Lyon, Lyon, France.
Karine MonierUniversité de Lyon, Centre de Recherche en Cancérologie de Lyon, Cancer Cell Plasticity Department, UMR INSERM 1052 CNRS, 5286, Centre Léon Bérard, Lyon, France.
Fabien MongelardUniversité de Lyon, Centre de Recherche en Cancérologie de Lyon, Cancer Cell Plasticity Department, UMR INSERM 1052 CNRS, 5286, Centre Léon Bérard, Lyon, France.
Philippe BouvetUniversité de Lyon, Centre de Recherche en Cancérologie de Lyon, Cancer Cell Plasticity Department, UMR INSERM 1052 CNRS, 5286, Centre Léon Bérard, Lyon, France. Philippe.bouvet@ens-lyon.fr.
Université Claude Bernard Lyon 1 · FRBiocon (India) · INBulgarian Academy of Sciences · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleolin is an essential protein that plays important roles in the regulation of cell cycle and cell proliferation. Its expression is up regulated in many cancer cells but its molecular functions are not well characterized. Nucleolin is present in the nucleus where it regulates gene expression at the transcriptional and post-transcriptional levels. Using HeLa cells depleted in nucleolin we performed an mRNA and miRNA transcriptomics analysis to identify biological pathways involving nucleolin. Bioinformatic analysis strongly points to a role of nucleolin in lipid metabolism, and in many signaling pathways. Down regulation of nucleolin is associated with lower level of cholesterol while the amount of fatty acids is increased. This could be explained by the decreased and mis-localized expression of the transcription factor SREBP1 and the down-regulation of enzymes involved in the beta-oxidation and degradation of fatty acids. Functional classification of the miRNA-mRNA target genes revealed that deregulated miRNAs target genes involved in apoptosis, proliferation and signaling pathways. Several of these deregulated miRNAs have been shown to control lipid metabolism. This integrated transcriptomic analysis uncovers new unexpected roles for nucleolin in metabolic regulation and signaling pathways paving the way to better understand the global function of nucleolin within the cell.

Indexed as

Gene Expression ProfilingComputational BiologyGene Expression RegulationHeLa CellsHumansLipid MetabolismMicroRNAsNucleolinPhosphoproteinsRNA-Binding ProteinsRNA, MessengerSignal TransductionMicroRNAsNucleolinPhosphoproteinsRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID28827664
PMCPMC5567140
OpenAlexW2750517504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.